WASHINGTON A new campaign aimed at raising education on the Medicare 2009 prescription drug coverage open enrollment window, from Nov. 15 to Dec. 31 of this year, is getting pushes from healthcare industry leaders.
As part of the campaign, results of a recent satisfaction survey were released which show that the vast majority of seniors are happy with their Medicare prescription drug coverage. Most seniors said that their plan adequately delivers what was promised when they signed up, Released survey results said. Also, about eight out of 10 seniors surveyed said they are “better off now than before the program.”
About 85 percent said that co-payments and monthly premiums are affordable. Ninety-one percent said their plans were a good value. And 71 percent said with their Medicare Part D plans they’ve lowered their prescription drug spending.
“It is extremely important for beneficiaries, especially those with limited income, to take advantage of the choice, convenience and cost savings that Medicare’s prescription drug plans offer them,” Healthcare Leadership Council president Mary Grealy said in a statement. “This national campaign will help make sure seniors are aware that now is the time to enroll in a plan or review their current Medicare drug plan.”
The Healthcare Leadership Council is a coalition of several healthcare companies and organizations.
A boost to the Medicare Part D open enrollment campaign includes TV ads, media reports and cooperation from more and grassroots organizations is spreading the message of increased satisfaction with Medicare Part D plans.
The survey was conducted by telephone and included patients 65 and older enrolled in Medicare during Sept. 16 through 22. The survey’s margin of error was reported at plus or minus 3.1 percent. The complete results are available at www.medicaretoday.org.
CVS Caremark taps Brennan as executive VP, chief medical officer
WOONSOCKET, R.I. CVS Caremark has appointed former Aetna executive Troyen Brennan as executive vice president and chief medical officer.
In this newly created role, Brennan will be responsible for MinuteClinic, Accordant Health Care, clinical and medical affairs, and health care strategy.
Most recently, Brennan served as chief medical officer for Aetna, the nation’s third largest health insurer. At Aetna, Brennan was responsible for clinical operations, national quality management, disease management and other programs. Before Aetna, Brennan was president and chief executive officer of Brigham and Women?s Physicians Organization in Boston, and also previously served that hospital as director of quality measurement and improvement. He is a member of the Institute of Medicine of the National Academy of Sciences.
“Troy Brennan is a highly regarded national health care expert who not only understands the challenges of health care today, but has hands on experience with all aspects of the health care delivery system. As a former practicing physician, hospital administrator with background in quality care measurement, and leader of a top health care insurer, Troy’s experience will help strengthen our company’s integrated approach to improving access, affordability and quality of care,” said Tom Ryan, chairman, chief executive officer and president of CVS Caremark. “He is a great addition to our management team.”
Walgreens unveils MedMonitor Complete; program will reduce costs, company says
DEERFIELD, Ill. Walgreens Health Services today unveiled a new drug utilization management program aimed at promoting prescription compliance among patients and holding down total healthcare costs.
The program, called MedMonitor Complete, is holistic in its approach, Walgreens noted. It uses an advanced, automated patient-matching process to provide a single clinical view of a patient, and maintains the patient’s claims history, even if they’ve changed their name, employer group or cardholder identification number.
MedMonitor integrates prescription and medical claims to review an entire population and identify patients’ risks for adverse drug events, according to the company. It also looks at the potential for patients’ non-compliance to “clinically appropriate standards of therapy.”
To boost compliance, clinical pharmacists communicate directly with patients and/or their health care professionals to alert them to drug-related problems such as over- or under-utilization, or opportunities to benefit from additional therapy. This process “effectively minimizes patient disruption while arming health care professionals with the necessary information to improve patient care,” Walgreens Health Services noted in a statement.
One large-scale application of the intervention program yielded $54 in savings per member per month, WHS added.
“Our goal with MedMonitor Complete is to provide healthcare professionals the most clinically relevant information that yields the greatest impact,” said Jim Langman, Walgreens’ vice president of clinical services. “The program’s impact calculations are pure, not artificially inflated with brand-to-generic conversions, step therapies and prior authorizations.”
Langman added that the results are “fully transparent,” allowing benefit managers to “clearly see reduced cost and positive health outcomes for their members.”